Watch CBS News

See the FDA's Photo Gallery of Alli Diet Drug Fakes; It's Triple Trouble for Meridia

GlaxoSmithKline (GSK)'s Alli and Abbott Labs (ABT)'s Meridia -- both diet drugs -- were both the subject of FDA warnings this week for the same reason: sibutramine.

The FDA warned consumers that there's a fake version of Alli on the market. It's filled not with orlistat (the active ingredient in Alli) but with sibutramine, the active ingredient in Meridia.

That's triple-y problematic because the FDA also demanded that Abbott Labs add a bunch of contraindications to Meridia after finding that among some patient groups "cardiovascular events occurred in 11.4% of patients using sibutramine [Meridia] compared to 10% of patients using a placebo." Meridia is now not to be used in anyone with a history of heart trouble. And in Europe, sibutramine was pulled from the market after authorities concluded its risks outweighed its benefits.

The counterfeit Alli is amazingly sophisticated. The FDA released a gallery of pictures (see below) to help consumers tell the difference between the fakes and the real stuff. The differences in the packaging are barely noticeable; the fakes use an eight-figure expiry date whereas the real thing has only a four-figure date stamp, for instance.

Other differences include:

  • Outer cardboard packaging missing a "Lot" code;
  • Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;
  • Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with "SEALED for YOUR PROTECTION";
  • Contains larger capsules with a white powder, instead of small white pellets.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.